The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19)

Phase 2

Recruiting

Conditions: SARS-cov2(COVID-19).
COVID-19, virus identified
U07.1

Registration Number: IRCT20180425039414N2

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

18 years of age or older
Diagnosis of COVID-19 by RT PCR and CT scan of the lungs
Blood oxygen levels are between 90 and 93 percent
Breathing rate between 20 and 24 per minute
Heart rate between 100 and 130 beats per minute

Exclusion Criteria

Intubation(mechanical ventilation)
Blood oxygen level below 90%
Breathing rate equal to 30 or more per minute
Allergic reaction to drugs
Shortness of breath caused by cardiogenic pulmonary edema
Pregnancy and lactation
History of oxygen therapy at home
Patients with end stage, lung, malignant, G6PD deficiency, diabetic ketoacidosis, cardiac arrhythmia

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical response. Timepoint: During hospitalization. Method of measurement: Cessation of fever, improvement of shortness of breath, reduction of cough, blood oxygenation (SaO2) and hemodynamic parameters.;Mortality. Timepoint: During hospitalization. Method of measurement: Count the number of dead patients.;Hospital stay. Timepoint: During hospitalization. Method of measurement: Count the number of hospital days to improve clinical symptoms.

Secondary Outcome Measures